Pediatrix Medical Group Target of Unusually High Options Trading (NYSE:MD)

Pediatrix Medical Group, Inc. (NYSE:MD) was the recipient of some unusual options trading activity on Wednesday. Investors acquired 6,020 put options on the stock. This is an increase of approximately 1,686% compared to the typical daily volume of 337 put options.

Insider Activity

In other news, Director Shirley A. Weis sold 36,028 shares of the stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.80% of the company’s stock.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Keybank National Association OH raised its position in Pediatrix Medical Group by 2.0% during the first quarter. Keybank National Association OH now owns 22,941 shares of the company’s stock valued at $491,000 after acquiring an additional 458 shares in the last quarter. Gotham Asset Management LLC grew its position in Pediatrix Medical Group by 0.6% in the third quarter. Gotham Asset Management LLC now owns 116,093 shares of the company’s stock worth $1,945,000 after acquiring an additional 724 shares in the last quarter. ProShare Advisors LLC grew its position in Pediatrix Medical Group by 4.6% in the fourth quarter. ProShare Advisors LLC now owns 16,816 shares of the company’s stock worth $360,000 after acquiring an additional 734 shares in the last quarter. Verition Fund Management LLC increased its stake in shares of Pediatrix Medical Group by 4.4% during the 3rd quarter. Verition Fund Management LLC now owns 25,408 shares of the company’s stock worth $426,000 after purchasing an additional 1,066 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Pediatrix Medical Group by 77.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 2,515 shares of the company’s stock worth $54,000 after purchasing an additional 1,100 shares during the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Up 6.1%

NYSE:MD traded up $1.46 during trading hours on Wednesday, hitting $25.57. The company’s stock had a trading volume of 418,104 shares, compared to its average volume of 803,316. The stock has a market capitalization of $2.10 billion, a P/E ratio of 12.40 and a beta of 0.66. The stock has a fifty day moving average of $23.72 and a 200-day moving average of $22.10. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45. Pediatrix Medical Group has a 52-week low of $11.84 and a 52-week high of $27.94.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.The firm had revenue of $476.20 million during the quarter, compared to the consensus estimate of $465.83 million. During the same period in the prior year, the company posted $0.33 earnings per share. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. On average, equities analysts forecast that Pediatrix Medical Group will post 2.1 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have commented on MD. Mizuho set a $24.00 price target on Pediatrix Medical Group in a research note on Friday, May 8th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Wednesday, June 24th. UBS Group increased their target price on Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 12th. Jefferies Financial Group restated a “buy” rating and set a $27.00 target price on shares of Pediatrix Medical Group in a report on Monday, April 20th. Finally, Truist Financial lifted their target price on Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research report on Tuesday. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $23.33.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.